nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—hematologic cancer	0.052	1	CbGaD
Pimozide—CYP1A2—Anagrelide—hematologic cancer	0.02	0.0355	CbGbCtD
Pimozide—CYP2E1—Thalidomide—hematologic cancer	0.0128	0.0227	CbGbCtD
Pimozide—ABCB1—Lenalidomide—hematologic cancer	0.0121	0.0215	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0117	0.0207	CbGbCtD
Pimozide—CYP3A7—Ifosfamide—hematologic cancer	0.0117	0.0207	CbGbCtD
Pimozide—CYP3A7—Imatinib—hematologic cancer	0.0111	0.0198	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0111	0.0198	CbGbCtD
Pimozide—CYP2E1—Dacarbazine—hematologic cancer	0.011	0.0196	CbGbCtD
Pimozide—CYP3A5—Daunorubicin—hematologic cancer	0.0109	0.0194	CbGbCtD
Pimozide—CYP2D6—Lomustine—hematologic cancer	0.0106	0.0189	CbGbCtD
Pimozide—CYP1A2—Carmustine—hematologic cancer	0.0105	0.0187	CbGbCtD
Pimozide—CYP3A5—Thalidomide—hematologic cancer	0.00993	0.0177	CbGbCtD
Pimozide—CYP3A5—Teniposide—hematologic cancer	0.00947	0.0169	CbGbCtD
Pimozide—CYP2D6—Idarubicin—hematologic cancer	0.00945	0.0168	CbGbCtD
Pimozide—CYP2C19—Bortezomib—hematologic cancer	0.0092	0.0164	CbGbCtD
Pimozide—CYP1A2—Methoxsalen—hematologic cancer	0.00892	0.0159	CbGbCtD
Pimozide—CYP3A5—Ifosfamide—hematologic cancer	0.00874	0.0156	CbGbCtD
Pimozide—CYP2E1—Mitoxantrone—hematologic cancer	0.00853	0.0152	CbGbCtD
Pimozide—CYP1A2—Bortezomib—hematologic cancer	0.00849	0.0151	CbGbCtD
Pimozide—CYP3A5—Imatinib—hematologic cancer	0.00835	0.0149	CbGbCtD
Pimozide—CYP1A2—Daunorubicin—hematologic cancer	0.00812	0.0144	CbGbCtD
Pimozide—CYP2D6—Hydroxyurea—hematologic cancer	0.00804	0.0143	CbGbCtD
Pimozide—CYP2C19—Thalidomide—hematologic cancer	0.00801	0.0143	CbGbCtD
Pimozide—CYP1A2—Alitretinoin—hematologic cancer	0.00795	0.0142	CbGbCtD
Pimozide—CYP2C19—Teniposide—hematologic cancer	0.00764	0.0136	CbGbCtD
Pimozide—CYP1A2—Thalidomide—hematologic cancer	0.00739	0.0132	CbGbCtD
Pimozide—CYP3A4—Bexarotene—hematologic cancer	0.00725	0.0129	CbGbCtD
Pimozide—ABCB1—Daunorubicin—hematologic cancer	0.0071	0.0126	CbGbCtD
Pimozide—CYP2C19—Ifosfamide—hematologic cancer	0.00705	0.0126	CbGbCtD
Pimozide—CYP2D6—Bortezomib—hematologic cancer	0.00699	0.0124	CbGbCtD
Pimozide—CYP3A7—Irinotecan—hematologic cancer	0.00696	0.0124	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00696	0.0124	CbGbCtD
Pimozide—ABCB1—Alitretinoin—hematologic cancer	0.00695	0.0124	CbGbCtD
Pimozide—CYP3A4—Lomustine—hematologic cancer	0.00674	0.012	CbGbCtD
Pimozide—CYP3A4—Busulfan—hematologic cancer	0.00674	0.012	CbGbCtD
Pimozide—CYP2C19—Imatinib—hematologic cancer	0.00674	0.012	CbGbCtD
Pimozide—CYP3A5—Dasatinib—hematologic cancer	0.00671	0.0119	CbGbCtD
Pimozide—CYP1A2—Dacarbazine—hematologic cancer	0.00636	0.0113	CbGbCtD
Pimozide—CYP1A2—Imatinib—hematologic cancer	0.00622	0.0111	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00608	0.0108	CbGbCtD
Pimozide—CYP3A7—Vincristine—hematologic cancer	0.00608	0.0108	CbGbCtD
Pimozide—CYP3A4—Thiotepa—hematologic cancer	0.00601	0.0107	CbGbCtD
Pimozide—ABCB1—Imatinib—hematologic cancer	0.00544	0.00968	CbGbCtD
Pimozide—CYP2E1—Etoposide—hematologic cancer	0.00538	0.00957	CbGbCtD
Pimozide—CYP3A5—Irinotecan—hematologic cancer	0.00522	0.00929	CbGbCtD
Pimozide—CYP2D6—Imatinib—hematologic cancer	0.00512	0.00912	CbGbCtD
Pimozide—CYP1A2—Dasatinib—hematologic cancer	0.00499	0.00889	CbGbCtD
Pimozide—ABCB1—Nilotinib—hematologic cancer	0.00494	0.00879	CbGbCtD
Pimozide—ABCB1—Vinorelbine—hematologic cancer	0.0049	0.00872	CbGbCtD
Pimozide—CYP3A4—Methoxsalen—hematologic cancer	0.00467	0.00832	CbGbCtD
Pimozide—CYP2D6—Nilotinib—hematologic cancer	0.00465	0.00829	CbGbCtD
Pimozide—CYP2D6—Vinorelbine—hematologic cancer	0.00462	0.00822	CbGbCtD
Pimozide—CYP3A7—Dexamethasone—hematologic cancer	0.00458	0.00815	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00458	0.00815	CbGbCtD
Pimozide—CYP3A5—Vincristine—hematologic cancer	0.00456	0.00812	CbGbCtD
Pimozide—CYP3A4—Bortezomib—hematologic cancer	0.00445	0.00791	CbGbCtD
Pimozide—CYP2C19—Prednisone—hematologic cancer	0.00444	0.0079	CbGbCtD
Pimozide—CYP2E1—Dexamethasone—hematologic cancer	0.00442	0.00787	CbGbCtD
Pimozide—ABCB1—Dasatinib—hematologic cancer	0.00437	0.00777	CbGbCtD
Pimozide—ABCB1—Mitoxantrone—hematologic cancer	0.00431	0.00768	CbGbCtD
Pimozide—CYP3A4—Daunorubicin—hematologic cancer	0.00425	0.00757	CbGbCtD
Pimozide—CYP3A5—Etoposide—hematologic cancer	0.00418	0.00744	CbGbCtD
Pimozide—ABCB1—Betamethasone—hematologic cancer	0.00384	0.00684	CbGbCtD
Pimozide—ABCB1—Gemcitabine—hematologic cancer	0.00381	0.00678	CbGbCtD
Pimozide—ABCB1—Prednisolone—hematologic cancer	0.00379	0.00675	CbGbCtD
Pimozide—CYP3A4—Cytarabine—hematologic cancer	0.00375	0.00668	CbGbCtD
Pimozide—CYP3A4—Teniposide—hematologic cancer	0.00369	0.00658	CbGbCtD
Pimozide—ABCB1—Prednisone—hematologic cancer	0.00358	0.00638	CbGbCtD
Pimozide—CYP3A5—Dexamethasone—hematologic cancer	0.00344	0.00612	CbGbCtD
Pimozide—CYP3A4—Ifosfamide—hematologic cancer	0.00341	0.00607	CbGbCtD
Pimozide—ABCB1—Irinotecan—hematologic cancer	0.0034	0.00604	CbGbCtD
Pimozide—CYP3A4—Imatinib—hematologic cancer	0.00326	0.0058	CbGbCtD
Pimozide—CYP1A2—Etoposide—hematologic cancer	0.00311	0.00554	CbGbCtD
Pimozide—CYP3A4—Ruxolitinib—hematologic cancer	0.00307	0.00546	CbGbCtD
Pimozide—ABCB1—Vinblastine—hematologic cancer	0.00302	0.00537	CbGbCtD
Pimozide—ABCB1—Vincristine—hematologic cancer	0.00297	0.00528	CbGbCtD
Pimozide—CYP3A4—Nilotinib—hematologic cancer	0.00296	0.00527	CbGbCtD
Pimozide—CYP3A4—Vinorelbine—hematologic cancer	0.00294	0.00522	CbGbCtD
Pimozide—CYP2D6—Vinblastine—hematologic cancer	0.00284	0.00506	CbGbCtD
Pimozide—CYP2C19—Dexamethasone—hematologic cancer	0.00277	0.00493	CbGbCtD
Pimozide—ABCB1—Cisplatin—hematologic cancer	0.00277	0.00493	CbGbCtD
Pimozide—Ezetimibe—ANPEP—hematologic cancer	0.00273	0.584	CrCbGaD
Pimozide—ABCB1—Etoposide—hematologic cancer	0.00272	0.00484	CbGbCtD
Pimozide—CYP3A4—Triamcinolone—hematologic cancer	0.00268	0.00478	CbGbCtD
Pimozide—CYP3A4—Dasatinib—hematologic cancer	0.00262	0.00466	CbGbCtD
Pimozide—CYP3A4—Mitoxantrone—hematologic cancer	0.00258	0.0046	CbGbCtD
Pimozide—CYP3A4—Betamethasone—hematologic cancer	0.0023	0.0041	CbGbCtD
Pimozide—CYP3A4—Prednisolone—hematologic cancer	0.00227	0.00404	CbGbCtD
Pimozide—ABCB1—Dexamethasone—hematologic cancer	0.00224	0.00398	CbGbCtD
Pimozide—CYP3A4—Prednisone—hematologic cancer	0.00215	0.00382	CbGbCtD
Pimozide—CYP2D6—Dexamethasone—hematologic cancer	0.00211	0.00375	CbGbCtD
Pimozide—CYP3A4—Irinotecan—hematologic cancer	0.00203	0.00362	CbGbCtD
Pimozide—ABCB1—Doxorubicin—hematologic cancer	0.00185	0.0033	CbGbCtD
Pimozide—CYP3A4—Vinblastine—hematologic cancer	0.00181	0.00322	CbGbCtD
Pimozide—ABCB1—Methotrexate—hematologic cancer	0.0018	0.0032	CbGbCtD
Pimozide—CYP3A4—Vincristine—hematologic cancer	0.00178	0.00317	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—hematologic cancer	0.00175	0.00311	CbGbCtD
Pimozide—CYP3A4—Etoposide—hematologic cancer	0.00163	0.0029	CbGbCtD
Pimozide—CYP3A4—Dexamethasone—hematologic cancer	0.00134	0.00238	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—hematologic cancer	0.00111	0.00198	CbGbCtD
Pimozide—OPRM1—hematopoietic system—hematologic cancer	0.000935	0.0386	CbGeAlD
Pimozide—HTR1A—hematopoietic system—hematologic cancer	0.000691	0.0285	CbGeAlD
Pimozide—CALM2—hematopoietic system—hematologic cancer	0.000679	0.028	CbGeAlD
Pimozide—CALM1—hematopoietic system—hematologic cancer	0.000676	0.0279	CbGeAlD
Pimozide—CYP2C19—hematopoietic system—hematologic cancer	0.000645	0.0266	CbGeAlD
Pimozide—Ezetimibe—ABCC3—hematologic cancer	0.00064	0.137	CrCbGaD
Pimozide—OPRM1—blood—hematologic cancer	0.00062	0.0256	CbGeAlD
Pimozide—KCNH2—hematopoietic system—hematologic cancer	0.000615	0.0254	CbGeAlD
Pimozide—CALM3—blood—hematologic cancer	0.000573	0.0236	CbGeAlD
Pimozide—CALM3—bone marrow—hematologic cancer	0.000554	0.0229	CbGeAlD
Pimozide—Ezetimibe—UGT1A1—hematologic cancer	0.000553	0.119	CrCbGaD
Pimozide—CYP1A2—hematopoietic system—hematologic cancer	0.000526	0.0217	CbGeAlD
Pimozide—CALM2—gonad—hematologic cancer	0.000516	0.0213	CbGeAlD
Pimozide—CALM1—gonad—hematologic cancer	0.000514	0.0212	CbGeAlD
Pimozide—OPRM1—testis—hematologic cancer	0.000513	0.0211	CbGeAlD
Pimozide—CYP3A5—hematopoietic system—hematologic cancer	0.000508	0.0209	CbGeAlD
Pimozide—CALM3—lung—hematologic cancer	0.000502	0.0207	CbGeAlD
Pimozide—HRH1—hematopoietic system—hematologic cancer	0.000493	0.0203	CbGeAlD
Pimozide—CALM3—testis—hematologic cancer	0.000474	0.0195	CbGeAlD
Pimozide—CYP2E1—hematopoietic system—hematologic cancer	0.000474	0.0195	CbGeAlD
Pimozide—CALM2—blood—hematologic cancer	0.00045	0.0185	CbGeAlD
Pimozide—CALM1—blood—hematologic cancer	0.000448	0.0185	CbGeAlD
Pimozide—CALM2—bone marrow—hematologic cancer	0.000435	0.0179	CbGeAlD
Pimozide—CALM1—bone marrow—hematologic cancer	0.000433	0.0179	CbGeAlD
Pimozide—CYP2C19—blood—hematologic cancer	0.000427	0.0176	CbGeAlD
Pimozide—HTR2A—hematopoietic system—hematologic cancer	0.000412	0.017	CbGeAlD
Pimozide—KCNH2—blood—hematologic cancer	0.000407	0.0168	CbGeAlD
Pimozide—CALM2—lung—hematologic cancer	0.000394	0.0163	CbGeAlD
Pimozide—KCNH2—bone marrow—hematologic cancer	0.000394	0.0163	CbGeAlD
Pimozide—CALM1—lung—hematologic cancer	0.000392	0.0162	CbGeAlD
Pimozide—CYP3A4—hematopoietic system—hematologic cancer	0.000381	0.0157	CbGeAlD
Pimozide—CYP2D6—hematopoietic system—hematologic cancer	0.000375	0.0155	CbGeAlD
Pimozide—CALM2—testis—hematologic cancer	0.000372	0.0153	CbGeAlD
Pimozide—CALM1—testis—hematologic cancer	0.00037	0.0153	CbGeAlD
Pimozide—DRD2—lung—hematologic cancer	0.000362	0.015	CbGeAlD
Pimozide—CYP1A2—blood—hematologic cancer	0.000349	0.0144	CbGeAlD
Pimozide—CALM3—lymph node—hematologic cancer	0.000343	0.0142	CbGeAlD
Pimozide—DRD2—testis—hematologic cancer	0.000342	0.0141	CbGeAlD
Pimozide—KCNH2—testis—hematologic cancer	0.000337	0.0139	CbGeAlD
Pimozide—CYP3A5—blood—hematologic cancer	0.000336	0.0139	CbGeAlD
Pimozide—CYP2E1—blood—hematologic cancer	0.000314	0.0129	CbGeAlD
Pimozide—HTR2A—gonad—hematologic cancer	0.000313	0.0129	CbGeAlD
Pimozide—Ezetimibe—ABCG2—hematologic cancer	0.000311	0.0666	CrCbGaD
Pimozide—CYP1A2—lung—hematologic cancer	0.000306	0.0126	CbGeAlD
Pimozide—CYP3A5—lung—hematologic cancer	0.000295	0.0122	CbGeAlD
Pimozide—HRH1—lung—hematologic cancer	0.000286	0.0118	CbGeAlD
Pimozide—CYP2E1—lung—hematologic cancer	0.000275	0.0113	CbGeAlD
Pimozide—HTR2A—blood—hematologic cancer	0.000273	0.0112	CbGeAlD
Pimozide—HRH1—testis—hematologic cancer	0.00027	0.0111	CbGeAlD
Pimozide—ABCB1—hematopoietic system—hematologic cancer	0.00027	0.0111	CbGeAlD
Pimozide—CALM2—lymph node—hematologic cancer	0.00027	0.0111	CbGeAlD
Pimozide—CALM1—lymph node—hematologic cancer	0.000268	0.0111	CbGeAlD
Pimozide—CYP2E1—testis—hematologic cancer	0.00026	0.0107	CbGeAlD
Pimozide—CYP3A4—blood—hematologic cancer	0.000252	0.0104	CbGeAlD
Pimozide—CYP2D6—blood—hematologic cancer	0.000248	0.0102	CbGeAlD
Pimozide—KCNH2—lymph node—hematologic cancer	0.000244	0.0101	CbGeAlD
Pimozide—HTR2A—lung—hematologic cancer	0.000239	0.00986	CbGeAlD
Pimozide—HTR2A—testis—hematologic cancer	0.000226	0.0093	CbGeAlD
Pimozide—CYP2D6—testis—hematologic cancer	0.000206	0.00848	CbGeAlD
Pimozide—ABCB1—gonad—hematologic cancer	0.000205	0.00846	CbGeAlD
Pimozide—HRH1—lymph node—hematologic cancer	0.000196	0.00807	CbGeAlD
Pimozide—ABCB1—blood—hematologic cancer	0.000179	0.00737	CbGeAlD
Pimozide—ABCB1—bone marrow—hematologic cancer	0.000173	0.00713	CbGeAlD
Pimozide—ABCB1—lung—hematologic cancer	0.000157	0.00646	CbGeAlD
Pimozide—ABCB1—testis—hematologic cancer	0.000148	0.0061	CbGeAlD
Pimozide—Ezetimibe—ABCB1—hematologic cancer	0.000129	0.0277	CrCbGaD
Pimozide—Astemizole—ABCB1—hematologic cancer	0.000129	0.0277	CrCbGaD
Pimozide—ABCB1—lymph node—hematologic cancer	0.000107	0.00442	CbGeAlD
Pimozide—Fexofenadine—ABCB1—hematologic cancer	9.22e-05	0.0198	CrCbGaD
Pimozide—Domperidone—ABCB1—hematologic cancer	8.42e-05	0.018	CrCbGaD
Pimozide—Drowsiness—Doxorubicin—hematologic cancer	4.38e-05	0.000218	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—hematologic cancer	4.38e-05	0.000218	CcSEcCtD
Pimozide—Anaemia—Prednisone—hematologic cancer	4.37e-05	0.000218	CcSEcCtD
Pimozide—Headache—Carmustine—hematologic cancer	4.36e-05	0.000217	CcSEcCtD
Pimozide—Shock—Dexamethasone—hematologic cancer	4.36e-05	0.000217	CcSEcCtD
Pimozide—Shock—Betamethasone—hematologic cancer	4.36e-05	0.000217	CcSEcCtD
Pimozide—Rash—Alitretinoin—hematologic cancer	4.35e-05	0.000217	CcSEcCtD
Pimozide—Nervous system disorder—Betamethasone—hematologic cancer	4.35e-05	0.000216	CcSEcCtD
Pimozide—Nervous system disorder—Dexamethasone—hematologic cancer	4.35e-05	0.000216	CcSEcCtD
Pimozide—Agitation—Prednisone—hematologic cancer	4.35e-05	0.000216	CcSEcCtD
Pimozide—Dermatitis—Alitretinoin—hematologic cancer	4.35e-05	0.000216	CcSEcCtD
Pimozide—Vomiting—Ifosfamide—hematologic cancer	4.34e-05	0.000216	CcSEcCtD
Pimozide—Tachycardia—Dexamethasone—hematologic cancer	4.33e-05	0.000215	CcSEcCtD
Pimozide—Tachycardia—Betamethasone—hematologic cancer	4.33e-05	0.000215	CcSEcCtD
Pimozide—Headache—Alitretinoin—hematologic cancer	4.32e-05	0.000215	CcSEcCtD
Pimozide—Diarrhoea—Gemcitabine—hematologic cancer	4.32e-05	0.000215	CcSEcCtD
Pimozide—Nausea—Thalidomide—hematologic cancer	4.31e-05	0.000214	CcSEcCtD
Pimozide—Rash—Ifosfamide—hematologic cancer	4.3e-05	0.000214	CcSEcCtD
Pimozide—Dermatitis—Ifosfamide—hematologic cancer	4.3e-05	0.000214	CcSEcCtD
Pimozide—Hyperhidrosis—Betamethasone—hematologic cancer	4.29e-05	0.000213	CcSEcCtD
Pimozide—Hyperhidrosis—Dexamethasone—hematologic cancer	4.29e-05	0.000213	CcSEcCtD
Pimozide—Dizziness—Irinotecan—hematologic cancer	4.28e-05	0.000213	CcSEcCtD
Pimozide—Urticaria—Etoposide—hematologic cancer	4.28e-05	0.000213	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—hematologic cancer	4.25e-05	0.000211	CcSEcCtD
Pimozide—Syncope—Prednisone—hematologic cancer	4.24e-05	0.000211	CcSEcCtD
Pimozide—Vomiting—Vincristine—hematologic cancer	4.23e-05	0.000211	CcSEcCtD
Pimozide—Anorexia—Dexamethasone—hematologic cancer	4.23e-05	0.00021	CcSEcCtD
Pimozide—Anorexia—Betamethasone—hematologic cancer	4.23e-05	0.00021	CcSEcCtD
Pimozide—Urticaria—Prednisolone—hematologic cancer	4.22e-05	0.00021	CcSEcCtD
Pimozide—Asthenia—Cisplatin—hematologic cancer	4.22e-05	0.00021	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—hematologic cancer	4.22e-05	0.00021	CcSEcCtD
Pimozide—Sweating—Doxorubicin—hematologic cancer	4.2e-05	0.000209	CcSEcCtD
Pimozide—Rash—Vincristine—hematologic cancer	4.19e-05	0.000209	CcSEcCtD
Pimozide—Dermatitis—Vincristine—hematologic cancer	4.19e-05	0.000209	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—hematologic cancer	4.18e-05	0.000208	CcSEcCtD
Pimozide—Headache—Vincristine—hematologic cancer	4.17e-05	0.000207	CcSEcCtD
Pimozide—Loss of consciousness—Prednisone—hematologic cancer	4.16e-05	0.000207	CcSEcCtD
Pimozide—Hypotension—Dexamethasone—hematologic cancer	4.14e-05	0.000206	CcSEcCtD
Pimozide—Hypotension—Betamethasone—hematologic cancer	4.14e-05	0.000206	CcSEcCtD
Pimozide—Nausea—Carmustine—hematologic cancer	4.14e-05	0.000206	CcSEcCtD
Pimozide—Vomiting—Mitoxantrone—hematologic cancer	4.12e-05	0.000205	CcSEcCtD
Pimozide—Vomiting—Irinotecan—hematologic cancer	4.12e-05	0.000205	CcSEcCtD
Pimozide—Nausea—Alitretinoin—hematologic cancer	4.1e-05	0.000204	CcSEcCtD
Pimozide—Convulsion—Prednisone—hematologic cancer	4.1e-05	0.000204	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—hematologic cancer	4.1e-05	0.000204	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—hematologic cancer	4.09e-05	0.000204	CcSEcCtD
Pimozide—Hypertension—Prednisone—hematologic cancer	4.09e-05	0.000203	CcSEcCtD
Pimozide—Rash—Mitoxantrone—hematologic cancer	4.08e-05	0.000203	CcSEcCtD
Pimozide—Rash—Irinotecan—hematologic cancer	4.08e-05	0.000203	CcSEcCtD
Pimozide—Dermatitis—Irinotecan—hematologic cancer	4.08e-05	0.000203	CcSEcCtD
Pimozide—Dermatitis—Mitoxantrone—hematologic cancer	4.08e-05	0.000203	CcSEcCtD
Pimozide—Headache—Mitoxantrone—hematologic cancer	4.06e-05	0.000202	CcSEcCtD
Pimozide—Headache—Irinotecan—hematologic cancer	4.06e-05	0.000202	CcSEcCtD
Pimozide—Nausea—Ifosfamide—hematologic cancer	4.05e-05	0.000202	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.04e-05	0.000201	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.04e-05	0.000201	CcSEcCtD
Pimozide—Myalgia—Prednisone—hematologic cancer	4.03e-05	0.000201	CcSEcCtD
Pimozide—Diarrhoea—Cisplatin—hematologic cancer	4.02e-05	0.0002	CcSEcCtD
Pimozide—Vomiting—Gemcitabine—hematologic cancer	4.01e-05	0.0002	CcSEcCtD
Pimozide—Insomnia—Betamethasone—hematologic cancer	4.01e-05	0.0002	CcSEcCtD
Pimozide—Insomnia—Dexamethasone—hematologic cancer	4.01e-05	0.0002	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4e-05	0.000199	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—hematologic cancer	3.98e-05	0.000198	CcSEcCtD
Pimozide—Rash—Gemcitabine—hematologic cancer	3.98e-05	0.000198	CcSEcCtD
Pimozide—Dermatitis—Gemcitabine—hematologic cancer	3.97e-05	0.000198	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—hematologic cancer	3.97e-05	0.000198	CcSEcCtD
Pimozide—Headache—Gemcitabine—hematologic cancer	3.95e-05	0.000197	CcSEcCtD
Pimozide—Nausea—Vincristine—hematologic cancer	3.95e-05	0.000197	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—hematologic cancer	3.95e-05	0.000196	CcSEcCtD
Pimozide—Urticaria—Triamcinolone—hematologic cancer	3.88e-05	0.000193	CcSEcCtD
Pimozide—Asthenia—Etoposide—hematologic cancer	3.87e-05	0.000192	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—hematologic cancer	3.87e-05	0.000192	CcSEcCtD
Pimozide—Decreased appetite—Betamethasone—hematologic cancer	3.85e-05	0.000192	CcSEcCtD
Pimozide—Decreased appetite—Dexamethasone—hematologic cancer	3.85e-05	0.000192	CcSEcCtD
Pimozide—Nausea—Mitoxantrone—hematologic cancer	3.85e-05	0.000192	CcSEcCtD
Pimozide—Nausea—Irinotecan—hematologic cancer	3.85e-05	0.000192	CcSEcCtD
Pimozide—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.83e-05	0.000191	CcSEcCtD
Pimozide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.83e-05	0.000191	CcSEcCtD
Pimozide—Pruritus—Etoposide—hematologic cancer	3.81e-05	0.00019	CcSEcCtD
Pimozide—Shock—Prednisone—hematologic cancer	3.8e-05	0.000189	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—hematologic cancer	3.79e-05	0.000189	CcSEcCtD
Pimozide—Nervous system disorder—Prednisone—hematologic cancer	3.79e-05	0.000189	CcSEcCtD
Pimozide—Tachycardia—Prednisone—hematologic cancer	3.77e-05	0.000188	CcSEcCtD
Pimozide—Skin disorder—Prednisone—hematologic cancer	3.75e-05	0.000187	CcSEcCtD
Pimozide—Nausea—Gemcitabine—hematologic cancer	3.75e-05	0.000187	CcSEcCtD
Pimozide—Vomiting—Cisplatin—hematologic cancer	3.74e-05	0.000186	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisone—hematologic cancer	3.73e-05	0.000186	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—hematologic cancer	3.73e-05	0.000186	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—hematologic cancer	3.72e-05	0.000185	CcSEcCtD
Pimozide—Rash—Cisplatin—hematologic cancer	3.71e-05	0.000185	CcSEcCtD
Pimozide—Dermatitis—Cisplatin—hematologic cancer	3.7e-05	0.000184	CcSEcCtD
Pimozide—Diarrhoea—Etoposide—hematologic cancer	3.69e-05	0.000183	CcSEcCtD
Pimozide—Anorexia—Prednisone—hematologic cancer	3.68e-05	0.000183	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—hematologic cancer	3.68e-05	0.000183	CcSEcCtD
Pimozide—Anaemia—Methotrexate—hematologic cancer	3.65e-05	0.000182	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—hematologic cancer	3.65e-05	0.000182	CcSEcCtD
Pimozide—Dizziness—Etoposide—hematologic cancer	3.56e-05	0.000177	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—hematologic cancer	3.56e-05	0.000177	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—hematologic cancer	3.54e-05	0.000176	CcSEcCtD
Pimozide—Urticaria—Dexamethasone—hematologic cancer	3.52e-05	0.000175	CcSEcCtD
Pimozide—Urticaria—Betamethasone—hematologic cancer	3.52e-05	0.000175	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.52e-05	0.000175	CcSEcCtD
Pimozide—Dizziness—Prednisolone—hematologic cancer	3.51e-05	0.000175	CcSEcCtD
Pimozide—Asthenia—Triamcinolone—hematologic cancer	3.51e-05	0.000175	CcSEcCtD
Pimozide—Nausea—Cisplatin—hematologic cancer	3.49e-05	0.000174	CcSEcCtD
Pimozide—Insomnia—Prednisone—hematologic cancer	3.49e-05	0.000174	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—hematologic cancer	3.49e-05	0.000174	CcSEcCtD
Pimozide—Pruritus—Triamcinolone—hematologic cancer	3.46e-05	0.000172	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—hematologic cancer	3.45e-05	0.000172	CcSEcCtD
Pimozide—Convulsion—Methotrexate—hematologic cancer	3.43e-05	0.000171	CcSEcCtD
Pimozide—Vomiting—Etoposide—hematologic cancer	3.43e-05	0.000171	CcSEcCtD
Pimozide—Anaemia—Epirubicin—hematologic cancer	3.42e-05	0.00017	CcSEcCtD
Pimozide—Agitation—Epirubicin—hematologic cancer	3.4e-05	0.000169	CcSEcCtD
Pimozide—Rash—Etoposide—hematologic cancer	3.4e-05	0.000169	CcSEcCtD
Pimozide—Dermatitis—Etoposide—hematologic cancer	3.39e-05	0.000169	CcSEcCtD
Pimozide—Headache—Etoposide—hematologic cancer	3.38e-05	0.000168	CcSEcCtD
Pimozide—Chest pain—Methotrexate—hematologic cancer	3.37e-05	0.000168	CcSEcCtD
Pimozide—Myalgia—Methotrexate—hematologic cancer	3.37e-05	0.000168	CcSEcCtD
Pimozide—Decreased appetite—Prednisone—hematologic cancer	3.36e-05	0.000167	CcSEcCtD
Pimozide—Rash—Prednisolone—hematologic cancer	3.35e-05	0.000167	CcSEcCtD
Pimozide—Dermatitis—Prednisolone—hematologic cancer	3.35e-05	0.000167	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.34e-05	0.000166	CcSEcCtD
Pimozide—Headache—Prednisolone—hematologic cancer	3.33e-05	0.000166	CcSEcCtD
Pimozide—Syncope—Epirubicin—hematologic cancer	3.32e-05	0.000165	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—hematologic cancer	3.31e-05	0.000165	CcSEcCtD
Pimozide—Constipation—Prednisone—hematologic cancer	3.3e-05	0.000164	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—hematologic cancer	3.29e-05	0.000164	CcSEcCtD
Pimozide—Palpitations—Epirubicin—hematologic cancer	3.27e-05	0.000163	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—hematologic cancer	3.25e-05	0.000162	CcSEcCtD
Pimozide—Dizziness—Triamcinolone—hematologic cancer	3.23e-05	0.000161	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—hematologic cancer	3.23e-05	0.000161	CcSEcCtD
Pimozide—Convulsion—Epirubicin—hematologic cancer	3.21e-05	0.00016	CcSEcCtD
Pimozide—Nausea—Etoposide—hematologic cancer	3.2e-05	0.000159	CcSEcCtD
Pimozide—Hypertension—Epirubicin—hematologic cancer	3.19e-05	0.000159	CcSEcCtD
Pimozide—Asthenia—Betamethasone—hematologic cancer	3.18e-05	0.000158	CcSEcCtD
Pimozide—Asthenia—Dexamethasone—hematologic cancer	3.18e-05	0.000158	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—hematologic cancer	3.16e-05	0.000158	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—hematologic cancer	3.16e-05	0.000158	CcSEcCtD
Pimozide—Nausea—Prednisolone—hematologic cancer	3.16e-05	0.000157	CcSEcCtD
Pimozide—Chest pain—Epirubicin—hematologic cancer	3.15e-05	0.000157	CcSEcCtD
Pimozide—Myalgia—Epirubicin—hematologic cancer	3.15e-05	0.000157	CcSEcCtD
Pimozide—Agitation—Doxorubicin—hematologic cancer	3.15e-05	0.000157	CcSEcCtD
Pimozide—Pruritus—Betamethasone—hematologic cancer	3.14e-05	0.000156	CcSEcCtD
Pimozide—Pruritus—Dexamethasone—hematologic cancer	3.14e-05	0.000156	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—hematologic cancer	3.13e-05	0.000156	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.13e-05	0.000156	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—hematologic cancer	3.12e-05	0.000155	CcSEcCtD
Pimozide—Vomiting—Triamcinolone—hematologic cancer	3.11e-05	0.000155	CcSEcCtD
Pimozide—Rash—Triamcinolone—hematologic cancer	3.08e-05	0.000153	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—hematologic cancer	3.08e-05	0.000153	CcSEcCtD
Pimozide—Dermatitis—Triamcinolone—hematologic cancer	3.08e-05	0.000153	CcSEcCtD
Pimozide—Anorexia—Methotrexate—hematologic cancer	3.08e-05	0.000153	CcSEcCtD
Pimozide—Syncope—Doxorubicin—hematologic cancer	3.07e-05	0.000153	CcSEcCtD
Pimozide—Urticaria—Prednisone—hematologic cancer	3.07e-05	0.000153	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—hematologic cancer	3.06e-05	0.000153	CcSEcCtD
Pimozide—Headache—Triamcinolone—hematologic cancer	3.06e-05	0.000152	CcSEcCtD
Pimozide—Diarrhoea—Dexamethasone—hematologic cancer	3.03e-05	0.000151	CcSEcCtD
Pimozide—Diarrhoea—Betamethasone—hematologic cancer	3.03e-05	0.000151	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—hematologic cancer	3.03e-05	0.000151	CcSEcCtD
Pimozide—Hypotension—Methotrexate—hematologic cancer	3.02e-05	0.00015	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—hematologic cancer	3.01e-05	0.00015	CcSEcCtD
Pimozide—Shock—Epirubicin—hematologic cancer	2.97e-05	0.000148	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—hematologic cancer	2.97e-05	0.000148	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—hematologic cancer	2.96e-05	0.000147	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—hematologic cancer	2.96e-05	0.000147	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—hematologic cancer	2.95e-05	0.000147	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.94e-05	0.000146	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—hematologic cancer	2.93e-05	0.000146	CcSEcCtD
Pimozide—Dizziness—Dexamethasone—hematologic cancer	2.93e-05	0.000146	CcSEcCtD
Pimozide—Dizziness—Betamethasone—hematologic cancer	2.93e-05	0.000146	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—hematologic cancer	2.92e-05	0.000145	CcSEcCtD
Pimozide—Insomnia—Methotrexate—hematologic cancer	2.92e-05	0.000145	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—hematologic cancer	2.92e-05	0.000145	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—hematologic cancer	2.92e-05	0.000145	CcSEcCtD
Pimozide—Nausea—Triamcinolone—hematologic cancer	2.9e-05	0.000144	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.9e-05	0.000144	CcSEcCtD
Pimozide—Anorexia—Epirubicin—hematologic cancer	2.88e-05	0.000143	CcSEcCtD
Pimozide—Somnolence—Methotrexate—hematologic cancer	2.87e-05	0.000143	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—hematologic cancer	2.85e-05	0.000142	CcSEcCtD
Pimozide—Hypotension—Epirubicin—hematologic cancer	2.82e-05	0.00014	CcSEcCtD
Pimozide—Vomiting—Dexamethasone—hematologic cancer	2.82e-05	0.00014	CcSEcCtD
Pimozide—Vomiting—Betamethasone—hematologic cancer	2.82e-05	0.00014	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—hematologic cancer	2.81e-05	0.00014	CcSEcCtD
Pimozide—Rash—Dexamethasone—hematologic cancer	2.8e-05	0.000139	CcSEcCtD
Pimozide—Rash—Betamethasone—hematologic cancer	2.8e-05	0.000139	CcSEcCtD
Pimozide—Dermatitis—Betamethasone—hematologic cancer	2.79e-05	0.000139	CcSEcCtD
Pimozide—Dermatitis—Dexamethasone—hematologic cancer	2.79e-05	0.000139	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.79e-05	0.000139	CcSEcCtD
Pimozide—Headache—Dexamethasone—hematologic cancer	2.78e-05	0.000138	CcSEcCtD
Pimozide—Headache—Betamethasone—hematologic cancer	2.78e-05	0.000138	CcSEcCtD
Pimozide—Asthenia—Prednisone—hematologic cancer	2.77e-05	0.000138	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.75e-05	0.000137	CcSEcCtD
Pimozide—Shock—Doxorubicin—hematologic cancer	2.75e-05	0.000137	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—hematologic cancer	2.74e-05	0.000136	CcSEcCtD
Pimozide—Pruritus—Prednisone—hematologic cancer	2.73e-05	0.000136	CcSEcCtD
Pimozide—Insomnia—Epirubicin—hematologic cancer	2.73e-05	0.000136	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—hematologic cancer	2.73e-05	0.000136	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—hematologic cancer	2.71e-05	0.000135	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—hematologic cancer	2.7e-05	0.000134	CcSEcCtD
Pimozide—Somnolence—Epirubicin—hematologic cancer	2.68e-05	0.000134	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—hematologic cancer	2.66e-05	0.000133	CcSEcCtD
Pimozide—Diarrhoea—Prednisone—hematologic cancer	2.64e-05	0.000132	CcSEcCtD
Pimozide—Nausea—Betamethasone—hematologic cancer	2.63e-05	0.000131	CcSEcCtD
Pimozide—Nausea—Dexamethasone—hematologic cancer	2.63e-05	0.000131	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—hematologic cancer	2.63e-05	0.000131	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—hematologic cancer	2.61e-05	0.00013	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.61e-05	0.00013	CcSEcCtD
Pimozide—Constipation—Epirubicin—hematologic cancer	2.58e-05	0.000129	CcSEcCtD
Pimozide—Urticaria—Methotrexate—hematologic cancer	2.56e-05	0.000128	CcSEcCtD
Pimozide—Dizziness—Prednisone—hematologic cancer	2.55e-05	0.000127	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.55e-05	0.000127	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—hematologic cancer	2.53e-05	0.000126	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—hematologic cancer	2.48e-05	0.000124	CcSEcCtD
Pimozide—Vomiting—Prednisone—hematologic cancer	2.46e-05	0.000122	CcSEcCtD
Pimozide—Rash—Prednisone—hematologic cancer	2.43e-05	0.000121	CcSEcCtD
Pimozide—Dermatitis—Prednisone—hematologic cancer	2.43e-05	0.000121	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—hematologic cancer	2.43e-05	0.000121	CcSEcCtD
Pimozide—Headache—Prednisone—hematologic cancer	2.42e-05	0.00012	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.41e-05	0.00012	CcSEcCtD
Pimozide—Urticaria—Epirubicin—hematologic cancer	2.4e-05	0.000119	CcSEcCtD
Pimozide—Constipation—Doxorubicin—hematologic cancer	2.39e-05	0.000119	CcSEcCtD
Pimozide—Asthenia—Methotrexate—hematologic cancer	2.32e-05	0.000115	CcSEcCtD
Pimozide—Nausea—Prednisone—hematologic cancer	2.29e-05	0.000114	CcSEcCtD
Pimozide—Pruritus—Methotrexate—hematologic cancer	2.28e-05	0.000114	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—hematologic cancer	2.22e-05	0.000111	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—hematologic cancer	2.21e-05	0.00011	CcSEcCtD
Pimozide—Asthenia—Epirubicin—hematologic cancer	2.17e-05	0.000108	CcSEcCtD
Pimozide—Pruritus—Epirubicin—hematologic cancer	2.14e-05	0.000106	CcSEcCtD
Pimozide—Dizziness—Methotrexate—hematologic cancer	2.13e-05	0.000106	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—hematologic cancer	2.07e-05	0.000103	CcSEcCtD
Pimozide—Vomiting—Methotrexate—hematologic cancer	2.05e-05	0.000102	CcSEcCtD
Pimozide—Rash—Methotrexate—hematologic cancer	2.03e-05	0.000101	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—hematologic cancer	2.03e-05	0.000101	CcSEcCtD
Pimozide—Headache—Methotrexate—hematologic cancer	2.02e-05	0.000101	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—hematologic cancer	2e-05	9.98e-05	CcSEcCtD
Pimozide—Dizziness—Epirubicin—hematologic cancer	2e-05	9.94e-05	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—hematologic cancer	1.98e-05	9.84e-05	CcSEcCtD
Pimozide—Vomiting—Epirubicin—hematologic cancer	1.92e-05	9.56e-05	CcSEcCtD
Pimozide—Nausea—Methotrexate—hematologic cancer	1.92e-05	9.54e-05	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—hematologic cancer	1.91e-05	9.52e-05	CcSEcCtD
Pimozide—Rash—Epirubicin—hematologic cancer	1.9e-05	9.48e-05	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—hematologic cancer	1.9e-05	9.47e-05	CcSEcCtD
Pimozide—Headache—Epirubicin—hematologic cancer	1.89e-05	9.42e-05	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—hematologic cancer	1.85e-05	9.2e-05	CcSEcCtD
Pimozide—Nausea—Epirubicin—hematologic cancer	1.79e-05	8.93e-05	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—hematologic cancer	1.78e-05	8.84e-05	CcSEcCtD
Pimozide—Rash—Doxorubicin—hematologic cancer	1.76e-05	8.77e-05	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—hematologic cancer	1.76e-05	8.76e-05	CcSEcCtD
Pimozide—Headache—Doxorubicin—hematologic cancer	1.75e-05	8.71e-05	CcSEcCtD
Pimozide—Nausea—Doxorubicin—hematologic cancer	1.66e-05	8.26e-05	CcSEcCtD
Pimozide—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.09e-06	6.99e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.09e-06	6.99e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.09e-06	6.99e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.09e-06	6.98e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MDM2—hematologic cancer	1.09e-06	6.96e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MDM2—hematologic cancer	1.09e-06	6.96e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—hematologic cancer	1.09e-06	6.95e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—hematologic cancer	1.09e-06	6.95e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.09e-06	6.95e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—hematologic cancer	1.09e-06	6.95e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—hematologic cancer	1.09e-06	6.95e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—EP300—hematologic cancer	1.09e-06	6.94e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EP300—hematologic cancer	1.08e-06	6.94e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.08e-06	6.93e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—EP300—hematologic cancer	1.08e-06	6.93e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—hematologic cancer	1.08e-06	6.93e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—hematologic cancer	1.08e-06	6.93e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—EP300—hematologic cancer	1.08e-06	6.9e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.08e-06	6.9e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.07e-06	6.87e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.07e-06	6.87e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.07e-06	6.87e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—hematologic cancer	1.07e-06	6.87e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.07e-06	6.86e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-06	6.83e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.07e-06	6.82e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—hematologic cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—hematologic cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—hematologic cancer	1.06e-06	6.77e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.06e-06	6.76e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—hematologic cancer	1.05e-06	6.74e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.05e-06	6.69e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—hematologic cancer	1.05e-06	6.68e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—EP300—hematologic cancer	1.04e-06	6.68e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—EP300—hematologic cancer	1.04e-06	6.68e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.04e-06	6.67e-06	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.04e-06	6.66e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.04e-06	6.64e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—hematologic cancer	1.04e-06	6.63e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.04e-06	6.62e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.03e-06	6.61e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.03e-06	6.61e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—hematologic cancer	1.03e-06	6.61e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—hematologic cancer	1.03e-06	6.6e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.03e-06	6.58e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	1.03e-06	6.57e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.03e-06	6.57e-06	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—hematologic cancer	1.03e-06	6.57e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.02e-06	6.52e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.02e-06	6.5e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.02e-06	6.5e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.02e-06	6.5e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.01e-06	6.49e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.01e-06	6.48e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.01e-06	6.48e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—hematologic cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—hematologic cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.01e-06	6.46e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—hematologic cancer	1.01e-06	6.44e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—hematologic cancer	1.01e-06	6.43e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—hematologic cancer	1e-06	6.42e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—hematologic cancer	1e-06	6.42e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1e-06	6.4e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—hematologic cancer	1e-06	6.4e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—hematologic cancer	9.98e-07	6.39e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—hematologic cancer	9.98e-07	6.39e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—hematologic cancer	9.98e-07	6.38e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—hematologic cancer	9.97e-07	6.38e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	9.94e-07	6.36e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	9.94e-07	6.36e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—hematologic cancer	9.92e-07	6.35e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—hematologic cancer	9.89e-07	6.33e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—hematologic cancer	9.88e-07	6.32e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—hematologic cancer	9.8e-07	6.27e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—hematologic cancer	9.78e-07	6.26e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—hematologic cancer	9.74e-07	6.23e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—hematologic cancer	9.74e-07	6.23e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	9.74e-07	6.23e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—hematologic cancer	9.72e-07	6.22e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—hematologic cancer	9.72e-07	6.22e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—hematologic cancer	9.71e-07	6.21e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—hematologic cancer	9.68e-07	6.19e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—hematologic cancer	9.68e-07	6.19e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—hematologic cancer	9.62e-07	6.16e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—hematologic cancer	9.6e-07	6.14e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CREBBP—hematologic cancer	9.58e-07	6.13e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	9.56e-07	6.11e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—hematologic cancer	9.55e-07	6.11e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—hematologic cancer	9.54e-07	6.11e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—hematologic cancer	9.53e-07	6.1e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—hematologic cancer	9.49e-07	6.07e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	9.48e-07	6.06e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—hematologic cancer	9.48e-07	6.06e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—hematologic cancer	9.48e-07	6.06e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—hematologic cancer	9.47e-07	6.06e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—hematologic cancer	9.46e-07	6.05e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—hematologic cancer	9.46e-07	6.05e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—hematologic cancer	9.46e-07	6.05e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—hematologic cancer	9.45e-07	6.05e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—hematologic cancer	9.45e-07	6.04e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	9.45e-07	6.04e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—hematologic cancer	9.43e-07	6.03e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—hematologic cancer	9.35e-07	5.98e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	9.3e-07	5.95e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—hematologic cancer	9.3e-07	5.95e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	9.27e-07	5.93e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK8—hematologic cancer	9.25e-07	5.92e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—hematologic cancer	9.24e-07	5.91e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—hematologic cancer	9.24e-07	5.91e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—hematologic cancer	9.23e-07	5.9e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—hematologic cancer	9.22e-07	5.9e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—hematologic cancer	9.22e-07	5.9e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	9.17e-07	5.87e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	9.17e-07	5.87e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—hematologic cancer	9.15e-07	5.85e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—hematologic cancer	9.15e-07	5.85e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—hematologic cancer	9.14e-07	5.85e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—hematologic cancer	9.09e-07	5.81e-06	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—hematologic cancer	9.06e-07	5.79e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EP300—hematologic cancer	9.02e-07	5.77e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—hematologic cancer	9e-07	5.76e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—hematologic cancer	8.97e-07	5.74e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK8—hematologic cancer	8.95e-07	5.73e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK8—hematologic cancer	8.95e-07	5.73e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—hematologic cancer	8.93e-07	5.71e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—hematologic cancer	8.93e-07	5.71e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—hematologic cancer	8.89e-07	5.69e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—hematologic cancer	8.84e-07	5.65e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—hematologic cancer	8.84e-07	5.65e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—hematologic cancer	8.82e-07	5.64e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—hematologic cancer	8.81e-07	5.63e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—hematologic cancer	8.78e-07	5.62e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—hematologic cancer	8.77e-07	5.61e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—hematologic cancer	8.75e-07	5.6e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—hematologic cancer	8.73e-07	5.58e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EP300—hematologic cancer	8.73e-07	5.58e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EP300—hematologic cancer	8.73e-07	5.58e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—hematologic cancer	8.72e-07	5.58e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—hematologic cancer	8.61e-07	5.51e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—hematologic cancer	8.59e-07	5.5e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3R1—hematologic cancer	8.58e-07	5.49e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—hematologic cancer	8.57e-07	5.48e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—hematologic cancer	8.54e-07	5.46e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—hematologic cancer	8.53e-07	5.46e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—hematologic cancer	8.53e-07	5.46e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—hematologic cancer	8.48e-07	5.43e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—hematologic cancer	8.48e-07	5.43e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—hematologic cancer	8.46e-07	5.41e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—hematologic cancer	8.44e-07	5.4e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—hematologic cancer	8.44e-07	5.4e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—hematologic cancer	8.43e-07	5.39e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—EP300—hematologic cancer	8.38e-07	5.36e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—hematologic cancer	8.26e-07	5.29e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—hematologic cancer	8.26e-07	5.29e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—hematologic cancer	8.24e-07	5.27e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—hematologic cancer	8.18e-07	5.23e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—hematologic cancer	8.18e-07	5.23e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—EP300—hematologic cancer	8.18e-07	5.23e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	8.17e-07	5.23e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—hematologic cancer	8.16e-07	5.22e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—hematologic cancer	8.16e-07	5.22e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—hematologic cancer	8.16e-07	5.22e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—hematologic cancer	8.16e-07	5.22e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—hematologic cancer	8.16e-07	5.22e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—hematologic cancer	8.16e-07	5.22e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—hematologic cancer	8.08e-07	5.17e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—hematologic cancer	8.08e-07	5.17e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	8.04e-07	5.14e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—hematologic cancer	8.03e-07	5.14e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	8.02e-07	5.13e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—hematologic cancer	8.01e-07	5.13e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—hematologic cancer	7.98e-07	5.1e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.98e-07	5.1e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.92e-07	5.07e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—hematologic cancer	7.9e-07	5.06e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.89e-07	5.05e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—hematologic cancer	7.86e-07	5.03e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—hematologic cancer	7.84e-07	5.02e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—hematologic cancer	7.82e-07	5e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—hematologic cancer	7.82e-07	5e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—hematologic cancer	7.78e-07	4.98e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—hematologic cancer	7.78e-07	4.97e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—hematologic cancer	7.76e-07	4.96e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—hematologic cancer	7.72e-07	4.94e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—hematologic cancer	7.72e-07	4.94e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—EP300—hematologic cancer	7.7e-07	4.93e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—hematologic cancer	7.63e-07	4.88e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—hematologic cancer	7.6e-07	4.86e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—hematologic cancer	7.6e-07	4.86e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—hematologic cancer	7.6e-07	4.86e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—hematologic cancer	7.58e-07	4.85e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—hematologic cancer	7.58e-07	4.85e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—hematologic cancer	7.56e-07	4.83e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—hematologic cancer	7.53e-07	4.82e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—hematologic cancer	7.53e-07	4.82e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—hematologic cancer	7.44e-07	4.76e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—hematologic cancer	7.42e-07	4.75e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CREBBP—hematologic cancer	7.4e-07	4.73e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—hematologic cancer	7.3e-07	4.67e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—hematologic cancer	7.26e-07	4.65e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—hematologic cancer	7.23e-07	4.63e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—hematologic cancer	7.12e-07	4.55e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—hematologic cancer	7.1e-07	4.54e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—hematologic cancer	7.03e-07	4.49e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—hematologic cancer	7.03e-07	4.49e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	7.01e-07	4.49e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.99e-07	4.47e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—hematologic cancer	6.92e-07	4.43e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—hematologic cancer	6.84e-07	4.38e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—hematologic cancer	6.67e-07	4.27e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	6.67e-07	4.27e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	6.62e-07	4.24e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—hematologic cancer	6.57e-07	4.2e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—hematologic cancer	6.56e-07	4.2e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—hematologic cancer	6.55e-07	4.19e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—hematologic cancer	6.55e-07	4.19e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—EP300—hematologic cancer	6.53e-07	4.17e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—hematologic cancer	6.52e-07	4.17e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—hematologic cancer	6.45e-07	4.13e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	6.45e-07	4.13e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	6.45e-07	4.13e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—hematologic cancer	6.45e-07	4.12e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—hematologic cancer	6.31e-07	4.03e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—hematologic cancer	6.31e-07	4.03e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—hematologic cancer	6.24e-07	3.99e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—hematologic cancer	6.24e-07	3.99e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	6.2e-07	3.96e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—hematologic cancer	6.17e-07	3.95e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.11e-07	3.91e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—hematologic cancer	6.05e-07	3.87e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—hematologic cancer	5.97e-07	3.82e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—hematologic cancer	5.97e-07	3.82e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—hematologic cancer	5.91e-07	3.78e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—hematologic cancer	5.72e-07	3.66e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—hematologic cancer	5.72e-07	3.66e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—hematologic cancer	5.7e-07	3.65e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—hematologic cancer	5.45e-07	3.49e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—hematologic cancer	5.28e-07	3.38e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—hematologic cancer	5.27e-07	3.37e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—hematologic cancer	5.27e-07	3.37e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—hematologic cancer	5.06e-07	3.24e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—EP300—hematologic cancer	5.04e-07	3.22e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—hematologic cancer	4.94e-07	3.16e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.83e-07	3.09e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—hematologic cancer	4.66e-07	2.98e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—hematologic cancer	3.94e-07	2.52e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.73e-07	2.38e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—hematologic cancer	3.04e-07	1.95e-06	CbGpPWpGaD
